Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Endoparasite control agent

a technology of endoparasites and agents, applied in the direction of antiparasitic agents, heterocyclic compound active ingredients, drug compositions, etc., can solve the problems of reducing the effectiveness of compound compounds, and remarkably reducing the incidence of parasitosis, so as to achieve better disinfection or control performance

Inactive Publication Date: 2016-12-22
THE UNIV OF TOKYO +1
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention provides a better way to control parasites that live inside the body. It works better at disinfecting or controlling these parasites than the previous methods.

Problems solved by technology

However, the literature does not describe that these compounds are effective for the disinfection or control of endoparasites in animals such as mammals and birds.
It is reported that the incidence of parasitosis in Japan has been remarkably decreased by improvement of environmental hygiene, but on a global scale, particularly in developing countries, parasitosis still widely prevails and causes tremendous damage.
Another problem is that immunodeficiency caused by mass administration of immunosuppressants, anticancer drugs, etc. or by AIDS etc. allows usually non-pathogenic or low-pathogenic parasites to express their pathogenicity and to cause opportunistic infection in hosts.
Further, parasitosis in domestic animals, such as pigs, horses, cattle, sheep, dogs, cats and domestic fowls, is a universal and serious economic problem.
That is, parasitic infection of domestic animals causes anemia, malnutrition, debility, weight loss, and serious damage of intestinal tract walls, tissues and organs, and may result in decline in feed efficiency and productivity, leading to a great economic loss.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Endoparasite control agent
  • Endoparasite control agent
  • Endoparasite control agent

Examples

Experimental program
Comparison scheme
Effect test

formulation example 1

Emulsion

[0278]Ten parts of a carboxamide derivative represented by the general formula (I) of the present invention, 6 parts of Sorpol 355S (surfactant, manufactured by Toho Chemical Industry), and 84 parts of Solvesso 150 (manufactured by Exxon) are uniformly mixed with stirring to give an emulsion.

formulation example 2

Ointment

[0279]One part of a carboxamide derivative represented by the general formula (I) of the present invention, 50 parts of white beeswax, and 43 parts of white petrolatum are well mixed to give an ointment.

formulation example 3

Tablet

[0280]Two parts of a carboxamide derivative represented by the general formula (I) of the present invention, 10 parts of vegetable oil (olive oil), 3 parts of crystalline cellulose, 20 parts of white carbon, and 65 parts of kaolin are well mixed and compressed into a tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is intended to provide a novel parasiticide, antiprotozoal or other endoparasite control agents which are effective for controlling animal endoparasites that have been impossible to control by conventional ones. Provided is an endoparasite control agent comprising, as an active ingredient, a carboxamide derivative represented by the general formula (I):or a salt thereof.

Description

FIELD[0001]The present invention relates an endoparasite control agent comprising a carboxamide derivative or a salt thereof as an active ingredient,, and a method for controlling endoparasites, comprising orally or parenterally administering the endoparasite control agent.BACKGROUND ART[0002]Certain kinds of carboxamide derivatives have been known to have microbicidal activity (see Patent Literature 1 to 12). However, the literature does not describe that these compounds are effective for the disinfection or control of endoparasites in animals such as mammals and birds. It is also known that certain kinds of carboxamide derivatives are effective against nematodes that may damage agricultural products (see Patent Literature 4 or 5), but there is no specific disclosure as to whether these compounds are effective against endoparasites in animals. Furthermore, there is a report that compounds that inhibit succinate-ubiquinone reductase (mitochondrial complex II), which is one of the re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/44A61K31/166
CPCA61K31/166A61K31/44A61P33/00A61P33/02A61P33/04A61P33/06A61P33/10A61P33/12C07C233/66C07C233/73C07D213/61C07D213/643C07D215/227C07D231/20C07D239/34C07D239/60C07D241/18C07D241/44C07D263/58C07D277/68
Inventor KITA, KIYOSHISUWA, AKIYUKIODA, MASATSUGU
Owner THE UNIV OF TOKYO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products